Prevention of adhesions post-abdominal surgery: Assessing the safety and efficacy of Chitogel with Deferiprone in a rat model by Vediappan, R.S. et al.
RESEARCH ARTICLE
Prevention of adhesions post-abdominal
surgery: Assessing the safety and efficacy of
Chitogel with Deferiprone in a rat model
Rajan Sundaresan VediappanID
1☯, Catherine Bennett1☯, Clare Cooksley1☯, John Finnie2☯,
Markus Trochsler3☯, Ryan D. QuarringtonID
4‡, Claire F. Jones4,5‡, Ahmed BassiouniID
1☯,
Stephen Moratti6☯, Alkis J. Psaltis1☯, Guy Maddern3☯, Sarah Vreugde1☯, P. J. Wormald1☯*
1 Department of Surgery—Otolaryngology Head and Neck Surgery, The University of Adelaide, Adelaide,
Australia, 2 SA Pathology and Adelaide Medical School, The University of Adelaide, Adelaide, Australia,
3 Department of Surgery, The University of Adelaide, Adelaide, Australia, 4 Adelaide Spinal Research
Group, Centre for Orthopaedic and Trauma Research, Adelaide Medical School, University of Adelaide,
Adelaide, Australia, 5 School of Mechanical Engineering, University of Adelaide, Adelaide, Australia,
6 Department of Chemistry, Otago University, Dunedin, New Zealand
☯ These authors contributed equally to this work.




Adhesions are often considered to be an inevitable consequence of abdominal and pelvic
surgery, jeopardizing the medium and long-term success of these procedures. Numerous
strategies have been tested to reduce adhesion formation, however, to date, no surgical or
medical therapeutic approaches have been successful in its prevention. This study demon-
strates the safety and efficacy of Chitogel with Deferiprone and/or antibacterial Gallium Pro-
toporphyrin in different concentrations in preventing adhesion formation after abdominal
surgery.
Materials and methods
112 adult (8–10 week old) male Wistar albino rats were subjected to midline laparotomy and
caecal abrasion, with 48 rats having an additional enterotomy and suturing. Kaolin (0.005g/
ml) was applied to further accelerate adhesion formation. The abrasion model rats were ran-
domized to receive saline, Chitogel, or Chitogel plus Deferiprone (5, 10 or 20 mM), together
with Gallium Protoporphyrin (250μg/mL). The abrasion with enterotomy rats were rando-
mised to receive saline, Chitogel or Chitogel with Deferiprone (1 or 5 mM). At day 21, rats
were euthanised, and adhesions graded macroscopically and microscopically; the tensile
strength of the repaired caecum was determined by an investigator blinded to the treatment
groups.
Results
Chitogel with Deferiprone 5 mM significantly reduced adhesion formation (p<0.01) when
pathologically assessed in a rat abrasion model. Chitogel with Deferiprone 5 mM and 1 mM
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also significantly reduced adhesions (p<0.05) after abrasion with enterotomy. Def-Chitogel
1mM treatment did not weaken the enterotomy site with treated sites having significantly
better tensile strength compared to control saline treated enterotomy rats.
Conclusions
Chitogel with Deferiprone 1 mM constitutes an effective preventative anti-adhesion barrier
after abdominal surgery in a rat model. Moreover, this therapeutic combination of agents is
safe and does not weaken the healing of the sutured enterotomy site.
Introduction
Seven million open abdominal surgeries occur each year in the US and Europe [1], costing the
health care system $USD 2.3 billion annually [2]. However, postsurgical adhesions are an
almost inevitable consequence of abdominal surgery and are the largest single cause of intesti-
nal obstruction [3]. Occurrence of adhesions after upper and lower abdominal surgery ranges
from 67–93% [4,5]. The mortality rate due to postsurgical adhesions can be high, especially
among the elderly [6], and these complications can cause chronic pain and female infertility
[7,8]. Prevention of adhesions aims to reduce inflammation and infection, which are the main
triggers of their formation. After surgery, inflammation results in extravasation of a fibrino-
gen-rich fluid, the resulting fibrin clot promoting adhesion formation, a process accentuated
by microbial contamination from leaked intestinal contents.
Numerous strategies have been devised to prevent peritoneal adhesions, such as hydro flo-
tation, barrier agents such as anti-adherence hyaluronic acid/carboxymethylcellulose, regener-
ated and expanded oxidised cellulose 0.5% in ferric hyaluronate and chlorine dioxide [5].
However, none of these strategies have been widely adopted due to poor efficacy or risk of
adverse events [9]. An ideal barrier agent should be a biocompatible substance that is suffi-
ciently flexible to conform to the abdominal cavity and able to be used during laparotomy or
laparoscopy. It should also be able to adhere to the peritoneal surface and remain in-situ for 5
to 7 days after the surgery. Moreover, it should prevent thrombin formation and hydrolyse,
without leaving degraded residue that is pro-inflammatory in nature.
Chitogel1 has been identified as an ideal candidate for this role. It is a dissolvable gel that
can carry Deferiprone (Def), an iron chelator, and Gallium-Protoporphyrin (GaPP) an anti-
bacterial haem analogue. Chitogel has been used extensively in the nasal cavity and sinuses as a
hemostatic and adhesion prevention agent with considerable success. It has good hemostatic
[10,11] and anti-adhesive properties [11–13], and an anti-microbial action [12]. Chitogel is
biocompatible, non-toxic [14,15], an excellent drug delivery device, and is currently a Food
and Drug Administration (FDA) approved postoperative dressing in sinuses post surgery. Pre-
vious in vivo studies conducted in small and large animal models of abdominal surgery sup-
port Chitogel’s anti-adhesive properties within the abdominal cavity [16,17]. Def is an FDA-
approved drug for the treatment of iron-overload conditions such as Thalassemia Major,
which has also been shown to reduce reactive oxygen species (ROS), an important contributor
to the inflammatory process in wound healing. In vitro Def has also been shown to reduce the
migration and proliferation of fibroblasts in a time and dose-dependent manner [18]. Impor-
tantly, Def is released from Chitogel within 48 to 72 hours, a critical time-frame for the preven-
tion of adhesion development [19].
GaPP has a similar structure to haem, with Gallium complexed in its center rather than
iron. Bacteria require iron for their metabolism and actively absorb GaPP. When used in
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combination with Def, Def-GaPP has demonstrated potent synergistic anti-microbial effects,
killing both Gram-positive and Gram-negative bacteria, including Multi Drug Resistant
(MDR) bacteria [20]. GaPP is released from Chitogel for up to 460 hours in vitro and in vivo
[19], making it available to bacteria long term.
This study sought to determine the lowest therapeutically relevant dose of Def required to
effectively reduce adhesion formation after abdominal surgery.
Materials & methods
The University of Adelaide and Central Adelaide Local Health Network/SA Pathology Animal
Ethics Committees (AEC) approved the study to be conducted at The Queen Elizabeth Hospi-
tal Experimental Surgical Suite (The University of Adelaide AEC M-2017-061 and CALHN/
SA Pathology AEC 25–17) and the AHMS Biomechanics Laboratory.
Animals
Male Wistar albino rats were purchased from Laboratory Animal Services Medical School
(The University of Adelaide, SA, Australia), 8 to 10 weeks old, with an average weight between
350 and 500 grams. Rats were housed 1 week prior to surgery under standard laboratory con-
ditions (temperature 21˚C ± 2˚C, humidity 55% ± 10%, 12: 12-hour light-dark-cycle). Rats
were housed in groups of 3 per cage and food and water were provided in a standard manner.
Materials
Kaolin (Aluminium silicate Hydroxide, Al2Si2O5(OH)4) was purchased from Sigma-Aldrich,
St. Louis, Missouri, United States (k7375-500G, Lot#SLN7548V).
1.1.1. Chitogel. The Chitogel is made up of a combination of three components;1% succi-
nyl chitosan, 0.3% phosphate buffer +/- 40% glycerol and 3% dextran aldehyde (Chitogel, Wel-
lington, NZ), (Product # MXR303). The components are manufactured and sterilized by
Chitogel. All stocks were stored at room temperature.
1.1.2. Deferiprone and Gallium Protoporphyrin. Deferiprone (3-hydroxy-1,2-dimethyl-
pyridin-4(1H)-one) (Sigma-Aldrich, St Louis, USA) (Lot # STBG8424) and Gallium Protopor-
phyrin IX (Ga-PP IX) (Frontier Scientific, Logan, USA) (Lot # JB18-12460) were stored at
room temperature.
Preparation of Chitogel
Dextran aldehyde (0.3 g) was dissolved in 10 mL of phosphate buffer +/- 40% glycerol then
mixed with 10 mL 1% succinyl chitosan.
Preparation of Chitogel-Deferiprone-Gallium protoporphyrin
Deferiprone (80 mM, 40 mM, 20 mM or 4mM) and Gallium Protoporphyrin (1 mg/mL) were
dissolved in 5 mL phosphate buffer (+/- 40% glycerol) under sterile conditions. For Def/GaPP
combination gel, 5 mL of each were added to dissolve dextran aldehyde prior to mixing with
10 mL of 1% succinyl chitosan. For Def gel, 5 mL Def solution plus 5 mL buffer were added to
dissolve dextran aldehyde prior to mixing with 10 mL of 1% succinyl chitosan.
Surgical procedure
Surgical procedures were performed by the same surgeons (RSV, CB) and a maximum group
size of five animals per day was used to ensure close monitoring during the immediate post-
operative period. Anaesthesia was achieved using a sealed chamber to deliver 2–3% Isoflurane,
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after which the animal was positioned supine for surgery and anaesthesia maintained with iso-
flurane over an open mask. Analgesia was provided preoperatively by subcutaneous injection
of Buprenorphine (0.05 mg/kg) and post-operative 8 hourly for 48 hours. The surgery was
conducted in aseptic manner and a prophylactic dosage of broad-spectrum antibiotic in the
form of Amoxycillin Clavulanic acid 5 mg/kg (Clavulox� Zoetis Australia, Rhodes, NSW, Aus-
tralia) was also administered via subcutaneous injection.
Rats underwent a laparotomy and a colon abrasion [16] or a colon abrasion with enterot-
omy [21]. Briefly, the abdomen was shaved and prepared with alcohol. After drying, a 3 cm
laparotomy (Fig 1A) was performed to gain access to the abdominal cavity. The caecum was
delivered and kept moist with saline-soaked gauze whilst a dry gauze was used to rub the cae-
cum repeatedly until sub-serosal bleeding occurred over an area of 1 cm2 (Fig 1B & 1C). 2 ml
0.005 g/mL Kaolin in saline was instilled over the abrasion [21]. The caecum was then returned
to the abdomen and the abdominal wall closed in layers with a 3–0 Polyglactin suture. Prior to
the placement of the final abdominal closure suture, rats were randomized to receive the fol-
lowing treatments into the abdominal cavity:
1. 4 mL normal saline, n = 12
2. 4 mL Chitogel, n = 12
3. 4 mL Chitogel + Def 20 mM + GaPP 250 μg/mL, n = 12
4. 4 mL Chitogel + Def 10 mM + GaPP 250 μg/mL, n = 12
5. 4 ml Chitogel + Def 5 mM + GaPP 250 μg/mL, n = 12
In the Caecal abrasion + enterotomy group rats, colon abrasion (dry rubbing of the caecum
wall over an area of 1 cm2 with gauze until bleeding occurs) and a full thickness enterotomy of
the caecum over a length of 10 mm at an adjacent site of Caecum was performed. The enterot-
omy was then closed with 4–0 PDS suture (resorbable, monofilament) (Fig 1D) and the repair
leak tested with a simple pressure test. 2 ml 0.005 g/mL Kaolin in saline was instilled over the
abrasion and sutured site, followed by application of 4 ml of the test treatments without glyc-
erol into the abdomen by randomization before closure of the abdominal wall as follows:
1. 4 mL normal saline, n = 12
2. 4 mL Chitogel, n = 12
3. 4 mL Chitogel + Def 5 mM n = 12
4. 4 mL Chitogel + Def 1 mM n = 12
The operation was limited to<15–20 mins each rat so as to avoid air drying of the organs.
Postoperative monitoring
Post-surgery, the animals were housed individually in separate cages at a constant room tem-
perature with a 12 h light and dark cycle. In the immediate post-operative period animals were
given Lectade Oral Rehydration Therapy (Lectade, Jurox Pty Limited, Australia) until they
were able to eat standard rodent food and drink water that were provided ad libitum. Animals
were monitored every 8-hours for the first 48 hours post-surgery. Their weight, behaviour,
physical well-being, and appearance were documented using the Clinical Record Sheet, as
approved by AEC. Adequate pain relief was maintained until 72 h post-surgery, and distress
scores higher than 6 or weight loss greater than 15% required that animals be euthanased.
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Fig 1. a. Incision over the Rat abdominal wall after preparation, (orange arrow) b. Identification of Caecum, c. Abrasion over the caecum with
gauze till bleeding spots appear, d. Enterotomy sutured, e. Adhesion induced by Kaolin at dosage of 0.005g/ml at day 21, f. Adhesion over the
enterotomy site at day 21.
https://doi.org/10.1371/journal.pone.0244503.g001
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Outcome measures
The animals were humanely killed using a CO2 gas inhalation chamber after 21 days post-
operative observation. Postmortem laparotomy was performed to assess adhesion formation
based on the presence and severity of adhesions using a previously validated adhesion scoring
system (Table 1) [16]. The score takes into account the number, strength and distribution of
adhesions formed. Pictures were taken with an iPhone 8 12mp ƒ/1.8 aperture camera (Fig 1E
& 1F) and a macroscopic grade was assigned to each rat by an abdominal surgeon who was
blinded to treatment. The intra-abdominal cavity was examined for any residual gel and con-
tents were examined for any gross changes.
Histology
The caecum with adhesion(s) was collected and the tissue between the caecal adventitia and
adherent adjacent intestinal serosal surfaces, and between the adventitial aspect of the caecum
and the parietal peritoneum of the abdominal wall, were collected and immersion-fixed in
10% neutral buffered formalin. These tissues were then paraffin-embedded, cut at 6 μm, and
stained with haematoxylin and eosin (H&E). Duplicate sections were also stained by the Mas-
son’s trichrome technique to demonstrate collagen deposition in fibrous adhesions. The slides
were examined, and scored, independently by two observers, blinded as to the treatment
groups.
In order to assess the nature of the intestinal adhesions produced by our experimental para-
digms, we attempted to grade these adhesions with respect to the stage of foreign body inflam-
matory reaction and degree of fibrosis.
Since there was some variability in the stage of these pathological processes between differ-
ent intestinal sites in a given animal, the adhesions were initially scanned at low magnification
(x4) and 3 sites selected for further analysis (at x20 magnification), these being areas of adhe-
sions most representative of the overall pathological reaction in each case (Fig 2).
In routine H&E—stained sections, the 3 sites selected were scored for inflammation and
wound healing according to an internally validated scoring system (Table 2):
These 3 sites were also evaluated in sections stained by the Masson’s trichrome technique
for quantity and quality of collagen deposition (Fig 3), and the Grades are shown in Table 3:
Tensile strength testing
After separation for histology, the caecal tissue was laid open and cut into a rectangular speci-
men (nominally 40 mm long and 9 mm wide) centred about the suture site (for the treatment
groups). The ends (5 mm) of each specimen were attached to custom plastic gripping tabs
(20×20 mm) using cyanoacrylate adhesive (Loctite 401, Henkel, Düsseldorf, Germany), giving
a gauge length of approximately 30 mm (Fig 4A). These gripping tabs assisted with fixing the
specimen into an electromechanical tensile testing machine (5543, Instron, High Wycombe,
Table 1. Adhesion scoring scheme.
Adhesion Scoring Scheme Score Description
0 No adhesions
1 Thin adhesion strands
2 Multiple thin adhesions
3 Thick adhesion with focal attachment
4 Thick adhesion with more broad-based planar attachment
5 Massive adhesions or more than one planar adhesion
https://doi.org/10.1371/journal.pone.0244503.t001
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Fig 2. H & E grading of caecal scar tissue 20X.
https://doi.org/10.1371/journal.pone.0244503.g002
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UK) via pneumatic grips (2712–019, Instron, High Wycombe, UK; 5 bar compressed air pres-
sure). Specimens were consistently placed in the grips with thicker colonic wall superiorly.
Prior to testing, a tensile pre-load of 0.01 N was applied; the specimen width above, below, and
at the suture site (middle for naïve tissue group), and specimen gauge length, were measured
using Vernier callipers (make, model etc). Tensile loading was applied at 0.1 mm/s until com-
plete failure occurred (Fig 5A). Loads and displacements were recorded at 100 Hz using a uni-
axial load cell (range ±10 N, Instron, High Wycombe, UK) and linear variable differential
transducer (position accuracy ± 0.02 mm), respectively. All tests were video recorded in high-
definition using a mobile-phone camera for qualitative analysis of the failure region.
Custom MATLAB code (R2015a, MathWorks, Massachusetts, USA) was developed to filter
the load and displacement data using a second-order, two-way Butterworth low-pass filter
with a cut-off frequency of 10 Hz, and load-displacement plots were generated. The peak load
and extension (displacement) at peak load were calculated. Stiffness (N/mm) was determined
from the linear region, the bounds of which were determined by a single operator, and a linear
regression line was fitted to the data points within this region to determine the slope.




predominantly epithelioid macrophage infiltration, with phagocytosed adhesion-inciting material, and
fewer multinucleated giant cells, lymphocytes and plasma cells
Grade 2
+
fibrovascular granulation tissue formation, with fibroblastic proliferation and supporting microvascular
angiogenesis, and a relatively small quantity of loosely arranged collagen
Grade 3
+
more mature fibroplasia with abundant collagen deposition
https://doi.org/10.1371/journal.pone.0244503.t002
Fig 3. MT staining of caecal scar tissue 20X.
https://doi.org/10.1371/journal.pone.0244503.g003
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Statistical analysis
Statistics of adhesion grades and histology were performed using R statistical software (R
Foundation for Statistical Computing, Vienna, Austria) through the Jupyter notebook inter-
face. The R package "MASS" [22] was used for ordinal regression. The "clm" function was used
to fit a Cumulative Link Model, with the semi-quantitative adhesion scores as the ordinal out-
come variable. The means of the ordinal response (interpreted as a numeric value from 1 to
the number of classes) were calculated and post-hoc pairwise contrasts for each pair of levels
of the treatment variable were compared using the "emmeans" package,(cite emmeans) with p-
value corrections for multiple comparisons applied using the False Discovery Rate (FDR)
method
Statistical analyses for the mechanical testing was performed using SPSS v22 (IBM, Illinois,
USA). Three linear regression models were developed to identify if treatment (naive, control,
gel alone, Chitogel with 1 mmol or 5 mmol of Def) was significantly associated with the follow-
ing outcome measures: 1) peak load, 2) extension at peak load, and 3) linear region stiffness.
Each model was developed as follows: Firstly, Shapiro-Wilk and Levene tests were performed
to assess normality and homogeneity of variance of the dependent variables, respectively. If
required, statistically significant outliers were removed to meet these criteria. The effect of
treatment was assessed in all models, and this effect was adjusted for the geometric measure-
ments taken of the specimens when under 0.01 N preload: thick-end width, middle (or suture
site) width, thin-end width, and length. Each model was refined using a manual backward
step-wise approach until only significant predictors remained (α = 0.05). Bonferroni-adjusted
post-hoc comparisons were used to determine differences between treatment group.
Results
Macroscopic adhesion scores
One hundred and eight rats underwent either colon abrasion (n = 60) or colon abrasion with
enterotomy (n = 48). Post-operative follow-up was uneventful for all rats with no major com-
plications up to day 21 after surgery. All 108 rats were recovered and at day 21 humanely killed
and observed for adhesions. All major organs were un-affected, and the abdominal cavity was
free of Kaolin or any residual products of Chitogel.
1.1.3. Abrasion model. The mean adhesion score in control rats treated with only saline
was 3.98 (CI 3.33, 4.63), and there were thick adhesions present over the site of abrasion in
most of the rats (Fig 4A, IV). Some were vascularized and had planar attachments between the
abdominal wall and the site of injury (Fig 4A III). The rats treated with Chitogel and Deferi-
prone 5 mM showed a significant reduction of the intra-abdominal adhesion scores macro-
scopically with a mean adhesion score of 2.77 (CI 2.19, 3.4) (p<0.01) (Fig 4B). Some of these
rats had a few very thin adhesion strands and in some there was more than one adhesion
strand (Fig 5, II). Rats treated with Chitogel alone had a mean adhesion score of 3.51 (CI 2.95,
4.08) and higher dosages of Def 10 mM and Def 20 mM had similar mean adhesion scores of
3.33 (CI 2.6, 4.06) & 3.64 (CI 2.77, 4.51) respectively.
Table 3. Grade of fibroblastic activity in the adhesion (Masson’s Trichrome).
Grade Description
Grade1+ minimal and loosely arranged collagen fibrils with numerous fibroblastic nuclei
Grade 2+ more abundant and compactly arranged collagen deposition
Grade 3+ mature collagenous connective tissue with compact collagen and markedly fewer fibroblastic nuclei
https://doi.org/10.1371/journal.pone.0244503.t003
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1.1.4. Colon abrasion with enterotomy model. Adhesions seen in this group of rats as
compared to the abrasion model were thicker and more abundant at the suture site. The mean
adhesion score of the control rats treated with saline in the colon abrasion with enterotomy
Fig 4. 4A. Photographs of rat abdomen at end point depicting different grades of adhesion. I—No adhesions, II—Thin
adhesion strands, III—Thich adhesions with focal attachment, IV—Thick adhesion with more broad-based planar
attachment, 4B Bar graph of blinded macroscopic grading of adhesion in a rat colon abrasion model, Mean grade
of adhesion after colon abrasion in rats treated with saline (n = 12), Chitogel (CD, n = 12), Chitogel with 5mM
Deferiprone (Def_5mM, n = 12), Chitogel with 10mM Deferiprone (Def_10mM, n = 12), Chitogel with 20mM
Deferiprone (Def_20mM, n = 12). �� p<0.01 compared to saline control, 4C; Bar graph of blinded macroscopic
grading of adhesion in an abrasion + enterotomy model, Mean grade of adhesion after colon abrasion + enterotomy
in rats treated with saline (n = 12), Chitogel (CD, n = 12), Chitogel with 1mM Deferiprone (Def_1mM, n = 12),
compared to saline control and Chitogel with 5mM Deferiprone (Def_5mM, n = 12), �p<0.05, 4D; Bar graph of
Masson’s Trichrome staining grading of caecal scars based on Table 3 Mean grade of fibrosis after colon abrasion in
rats treated with saline (n = 12), Chitogel (CD, n = 12), Chitogel with 20mM Deferiprone (Def_20mM, n = 12),
Chitogel with 10mM Deferiprone (Def_10mM, n = 12), Chitogel with 5mM Deferiprone (Def_5mM, n = 12).
https://doi.org/10.1371/journal.pone.0244503.g004
Fig 5. Electromechanical tensile strength testing. (A) Experimental set up showing specimen caecum split open and fixed to the Instron pneumatic arms with sutured
area at its centre before being stretched (thick white arrow indicates direction of pull) for electromechanical tensile testing. (B) Load displacement graph showing value of
tensile force [in Newton(N)] vs displacement [in millimetre(mm)]. The red line represents the linear region, from which the stiffness was calculated, and the red circle
indicates the peak load location. (C) Bar graph of peak axial force [in Newton (N)] for the different treatment groups ���p<0.001, � p<0.05, (D) Bar graph of Linear region
stiffness [in Newton/mm (N/mm)] of caecum in different treatment groups specimens. ��� p<0.001, compared to Naïve tissue.
https://doi.org/10.1371/journal.pone.0244503.g005
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group was 4.87 (CI 4.36, 5.38). Rats treated with Chitogel alone had similar adhesion scores of
4.43 (CI 3.88, 4.9) compared to control (p>0.05). The rats treated with Chitogel in combina-
tion with 2 low dosages of Deferiprone of 5 mM and 1 mM, showed significant reductions of
abdominal adhesions macroscopically with mean adhesion scores of 3.66 (CI 3.12, 4.21) and
3.69 (CI 3.06, 4.32) respectively (p<0.05) (Fig 4C).
3.2. Histopathology
Caecal adhesions and scar tissue from control rats in both the abrasion and abrasion with
enterotomy models showed inflammation and mature adhesions with abundant compact col-
lagen and few fibroblasts. The caecal scar tissue from rats treated with Chitogel and Def
showed predominantly epithelioid macrophage infiltration, with phagocytosed adhesion-incit-
ing material, with fewer multinucleated giant cells, lymphocytes and plasma cells. Masson Tri-
chrome staining of adhesions showed a significant reduction in fibroblastic activity with
reduced collagen deposition in rats treated with Chitogel with lower dosages of Def in the rat
abrasion model (Def 5mM p<0.05and Def 10mM P<0.05) (Fig 4D). There was similar reduc-
tion of fibroblastic activity in the enterotomy model (Def 5mM & 1mM) but this was not statis-
tically significant (Fig 4E).
Tensile strength testing
Electromechanical tensile strength testing revealed differences between samples of the localisa-
tion of tissue rupture (S2 Table). Naïve caecum colon mucosa ruptured 7/12 mid-specimen
(58.3%) and 5/12 (41.7%) in the lower, thinner part of the mucosa and none in the upper,
thicker part of the mucosa (Fig 5A and 5I). In contrast, in control colon anastomosis samples,
colon mucosa ruptured 2/11 mid-specimen (18%), 3/11 (27%) in the upper, thicker part of the
mucosa and 6/11 (54%) in the lower, thinner part of the mucosa. Chitogel with Def 1mM and
Def 5 mM treated colon anastomosis never failed within the repair zone and rupture sites were
similar with 0/22 ruptures occurring mid-specimen (0% of all ruptures), 8/22 (36%) in the
upper, thicker part of the mucosa and 14/22 (64%) in the lower, thinner part of the mucosa,
whereas 1/12 (8%) failed at the repair zone in Chitogel alone treated wound. All enterotomy
groups (i.e. control, Chitogel and Chitogel with Def 5mm), except the Chitogel with Def 1 mM
group (p = 0.142), had significantly lower peak loads than the naïve tissue (p<0.05). Def 1mM
and Def 5 mM had significantly larger peak loads than Chitogel Only (p<0.001 and p = 0.049,
respectively) (Fig 5C). All “repaired” specimens had significantly lower stiffness than the naïve
tissue (p<0.001 for all) (Fig 5D).
Discussion
While Chitogel has well documented anti-adhesive properties [16,17,23], this study demon-
strated that the addition of Deferiprone at lower concentrations of 5 mM and 1 mM to Chito-
gel further improved Chitogel’s anti-adhesive properties. This resulted in a significant
reduction in adhesions in the abdominal cavity post abdominal surgery when assessed macro-
scopically and microscopically. Moreover, although the adhesions produced in the positive
control animals were robust due to the presence of an inducing agent, histopathological data
showed reduced collagenous connective tissue in Def-Chitogel treated animals. Importantly,
the addition of 1 mM and 5 mM Def to Chitogel did not reduce the strength of the scar tissue.
Def 1mM and Def 5 mM treated sites never failed at the repair site and an increase in peak
load was observed when compared to Chitogel alone. In fact, peak load, indicative of wound
healing of enterotomy sites, was significantly higher when Def 1mM-Chitogel was applied
compared to control saline treated enterotomy sites and was similar to naïve, non-operated
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tissue. Together, these results indicate that Def 1mM-Chitogel, apart from reducing post-oper-
ative adhesions, actively promotes wound healing of the enterotomy site. This data supports
the excellent potential of Def 1mM-Chitogel as an anti-adhesion device for use after open
abdominal surgery with and without enterotomy.
Wound healing after abdominal surgery is a complex process and, to a large extent, depends
on the site and organs involved [24]. Adhesions are common after surgery on the abdominal
wall, abdominal viscera, and the urogenital system [3]. While adhesions formed after perito-
neal injury are uniquely formed by sheets of mesothelium [25], most abdominal adhesions are
formed by organisation of a fibrin-rich haematoma and characterised by infiltration of fibro-
vascular granulation tissue, the fibroblastic component laying down collagen, which forms the
healed scar tissue. This process of post-surgical blood clot organisation is further complicated
and impeded by inflammation and infection. To date, there have been various strategies
devised to prevent adhesions, mainly in the form of peritoneal irrigates, instillates or barriers
[26]. The application of silastic sheets within 36 hours of surgery, for example, is able to reduce
adhesion formation from 100% to 0% [26].
However, although barrier systems have proven to be useful in reducing adhesions, no
agent has progressed to widespread clinical use, in large part due to the lack of clinical efficacy
or undesirable side effects [27]. Adhesion-reducing liquid barriers, such as icodextrin solution
or polyethylene glycol, rely on the principle of hydro-flotation, but have not been proven use-
ful in all situations [4]. Films such as oxidised regenerated cellulose [26] or hyaluronate
carboxymethylcellulose act as a mechanical barrier, separating the operative surfaces within
the abdomen. While these are solid barriers, their solubility and longevity in the abdomen
remain problematic and they have limited role in laparoscopic surgery [28].
Chitogel has been extensively studied in ENT surgery as a post-operative dressing in the
nasal and sinus cavities [11,13,29–32]. The viscous nature of Chitogel enables it to conform to
narrow spaces [13,33,34] and deliver anti-adhesive and anti-microbial drugs in chronic sinusi-
tis surgery [35,36]. In order to prevent intra-abdominal adhesion formation, post-surgical
haemorrhage, inflammation and inhibition of inflammatory cytokine-driven fibroblastic infil-
tration are required [37]. Chitogel has haemostatic [11], anti-inflammatory and anti- prolifer-
ative properties [12]. Deferiprone’s potent anti-inflammatory and inhibitory effects on
fibroblast migration potentiate Chitogel’s anti-adhesive properties [18]. Def also has inhibitory
effects on Reactive Oxygen Species (ROS) generation and collagen secretion by primary fibro-
blasts [18]. This combined effect results in reduced fibrosis in the rat abdomen treated with
Chitogel and Deferiprone when compared to Saline and Chitogel alone in both our abrasion
and enterotomy with abrasion models. The Def release profile from Chitogel has shown that
the complete release of Def occurs within 72 h [19] and maximum serum levels are reached
within 24 h [36]. These findings indicate that Def affects wound healing in the early stages of
wound repair, a time when the production of ROS and associated inflammation is maximal
[18]. Histological findings in the present study are concordant with these actions in the form
of reduced fibroblastic proliferation and attenuated collagen deposition.
While the anti-fibrotic effect of some interventions such as hyaluronic acid–based films,
reduce the quality of wound healing [38] and promote fistula formation [39], the tensile
strength of caecal tissue treated with Def-Chitogel in the present study was not compromised.
In the enterotomy part of this study, the antimicrobial GaPP was omitted as no microor-
ganisms were cultured from the abdominal cavity in the control animals at day 21. Without a
positive bacteriological swab at day 21, we would have been unable to show any benefit of add-
ing GaPP. Moreover, lower Def dosages of 5 mM and 1 mM were used in this cohort because
our results indicated an inverse dose response when using Def dosages of 10mM and above. A
previous sheep laminectomy study similarly showed reduced anti-adhesive capacity of Def-
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Chitogel when Def concentrations above 20 mM were used [40]. The reason for this reduced
anti-adhesive capacity at high Def concentrations in Chitogel is unclear. Ramezanpour et al
showed no significant toxicity when 10 mM Def was applied to primary fibroblasts and pri-
mary human nasal epithelial cells for up to 48 hours [18]. In that study, Def at higher concen-
trations of 10 and 20 mM had stronger anti-inflammatory properties than corticosteroids at
clinically relevant concentrations. Whilst excessive inflammation can induce adhesions, it is
well known that a low degree of inflammation is needed as part of the normal healing process
after surgery [41]. Therefore, Def concentrations in excess of 10 mM might deregulate this bal-
ancing act resulting in a loss of beneficial anti-adhesive and wound healing properties. Reduc-
ing inflammation may also delay healing at the level of suture lines or anastomotic sites
therefore demonstration of conserved tissue-holding strength of sutures and anastomotic sites
is critical for abdominal adhesion barrier devices in particular if those are to be used in indica-
tions of enterotomy. The enterotomy part of our study replicates the clinical indication of
open invasive abdominal surgery, e.g. involving the removal or opening of the gut with the
associated intra-abdominal bacterial contamination that occurs with such an enterotomy. The
tensile strength tests performed demonstrated that Chitogel with Def concentrations of 5mM
and 1 mM was safe and allowed for a normal caecal wound healing to occur. In fact, Def-Chit-
ogel at 1 mM Def concentration resulted in anastomotic sites that had superior tissue strength
than Chitogel treated animals without any significant difference with naïve rats that did not
undergo abrasion/enterotomy. These results indicate that Chitogel with 1mM Def not only
prevents adhesion formation but also promotes efficient healing of the enterotomy site, setting
this product apart from all other marketed adhesion barrier devices. Whilst further research is
needed to confirm these promising findings in large animal models of abdominal surgery, our
results support the potential beneficial properties of Chitogel incorporating 1mM Def for use
to prevent adhesions after abdominal surgery with enterotomy.
In conclusion, the results of this rat study demonstrated that Chitogel with 1mM Deferi-
prone is a safe and effective product significantly reducing abdominal adhesion formation.
Confirmation of safety and anti-adhesive properties in large animal models are required prior
to advancing this technology towards human clinical trials.
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